Bayer in Court, BMW's Plunge, LVMH Breather

On this episode of Stock Movers:- 3M (MMM) shares fall after the industrial company gave an outlook for this year’s adjusted earnings per share with a midpoint below what analysts expected. JPMorgan says the company had a “mixed” end to 2025, with adjusted organic growth missing ...  Show more

On this episode of Stock Movers:- GSK (GSK) agreed to buy Rapt Therapeutics (RAPT), a US-based biotech developing treatments for patients with inflammatory and immunologic diseases, in a deal valued at $2.2 billion. The UK drug company will pay $58 a share, equivalent to an equit ...  Show more

On the final trading day of what has been a strong April for stocks, Carl Quintanilla and Jim Cramer led off the show with a look at blowout quarterly results from Amazon which sent the stock higher. They explored Amazon's dominance over retail and the strength in its Amazon Web ...  Show more

Carl Quintanilla, Jim Cramer and David Faber breakdown the big swings in the market. Stocks jumping at the open as Wall Street tries to shrug off its worst day in two years. Experts still urging caution over the coronavirus, as cases outside of China continue to rise. Masterca ...

Carl Quintanilla, Jim Cramer and David Faber let off the show by discussing working our way back to normal: Jim and David being on set together for the first time in 13 months. They segued to Bitcoin's weekend sell-off and what it means for cryptocurrency and shares of Coinbase ...  Show more

Carl Quintanilla, Jim Cramer and David Faber began a new week with a look at tech stocks under pressure, after Citi downgraded Facebook and Google parent Alphabet to neutral. But that news didn't stop the Dow from hitting a new all-time intraday high -- as money rotates out of te ...  Show more